Interpol and 29 of the world’s largest pharmaceutical companies have launched another initiative to combat the spread of counterfeit drugs.
The three-year deal will see the drugmakers put in 4.5 million euros towards the creation of Interpol’s Pharmaceutical Crime Programme. It is hoped the initiative can further build on the work of the latter's Medical Product Counterfeiting and Pharmaceutical Crime unit and "enhance the law enforcement community’s response" to the problem through stronger partnership development.
No comments:
Post a Comment